Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid is a drugstore chain that offers prescription medications, over-the-counter drugs, and health and wellness products. Rite Aid is reshaping the concept of a modern pharmacy by catering to customer demands through various convenient channels, including retail and delivery pharmacy services. Additionally, the company's offerings extend to services provided by its wholly-owned subsidiaries, namely Elixir, Bartell Drugs, and Health Dialog. Elixir, Rite Aid’s pharmacy benefits and services company, encompasses accredited mail and specialty pharmacies, prescription discount programs, and an advanced adjudication platform. These components combine to provide exceptional member experiences and substantial cost savings. Furthermore, Health Dialog delivers healthcare coaching and disease management services through interactive live online sessions and phone-based health services.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

Investors need to pay close attention to Rite Aid (RAD) stock based on the movements in the options market lately.

Options Traders Expect Huge Moves in Rite Aid (RAD) Stock

Amazon

Amazon.com Inc. AMZN, +1.04% said Thursday that it has launched Counter, a third-party package pickup service that will allow customers to retrieve their orders with same-day, one-day and standard shipping service.

Amazon launches package pickup service Counter with Rite Aid partnership

Amazon’s strategy to bring more brick-and-mortar options into its vast e-commerce empire, and its ambition to sell more pharmaceutical products, today may have found themselves a little more knitted together. The company announced a new service in the US called Counter, a free in-store pick-up service where Amazon shoppers can arrange to collect packages.

Amazon launches Counter in-store pick-up in the US, starting with 100 Rite Aid locations

The big pharmacy retailer missed Wall Street estimates on both the top and bottom lines.

Rite Aid Delivers Another Disappointment With Its Q1 Results

Amazon is teaming up with Rite Aid as part of a new package pickup service that further expands the tech giant’s growing delivery logistics network.

Amazon partners with Rite Aid for new in-store package pickup option, expanding logistics network

Amazon.com has steadily added options for customers to receive their packages including in car trunks, inside home garages and potentially by drone.

Amazon launches new in-store pickup option with Rite Aid as first partner

Rite Aid Corporation (RAD) CEO John Standley on Q1 2020 Results - Earnings Call Transcript

Pier 1 Imports

It wasn't a very happy results reporting day for the two struggling retailers.

After Hours: Rite Aid, Pier 1 Both Hit by Poor Q1s

Shares of Rite Aid Corp. RAD, +3.80% fell more than 10% in the extended session Wednesday after the retailer reported a larger-than-expected fiscal first-quarter loss.

Rite Aid stock falls 10% after larger-than-expected quarterly loss

Shares of the pharmacy chain jumped on renewed hopes for an acquisition.

Why Rite Aid Stock Popped Today

Rite Aid's (RAD) first-quarter fiscal 2020 results should gain from growth initiatives, and momentum in retail and pharmacy businesses. However, a bleak outlook raises concerns.

Can Rite Aid (RAD) Beat on Earnings in Q1 Despite Soft View?

Rite Aid (RAD) partners with Adobe to accelerate digital transformation and boost customer experience across all channels.

Rite Aid Partners with Adobe, Digital Business to Benefit

Meet Group

Dave & Buster's

Rite Aid, Dave & Buster's, and The Meet Group hit new lows after another rough week.

Three Surprising Stocks Hitting New Lows Last Week

CVS Health

Designer Brands

Simon Property Group

Ulta Beauty

Urban Outfitters

Walgreens

Cannabidiol sales could tally $22 billion by 2022, and these brand-name companies want their piece of the pie.

9 Major Retailers That Are Selling CBD Products

Rite Aid (RAD) reported earnings 30 days ago. What's next for the stock?

Rite Aid (RAD) Down 22.3% Since Last Earnings Report: Can It Rebound?

The market was none too pleased about the pharmacy retail chain's progress last quarter.

Why Rite Aid Stock Plummeted 27.9% in April

The drugstore operator's 1-for-20 reverse split means that the stock is in compliance, but investors continue to bail on the poorly performing investment.

How's That Reverse Split Working Out for You, Rite Aid?

Rite Aid will raise the minimum age to buy tobacco products to 21 within the next 90 days.

Rite Aid raises tobacco buying age to 21, following Walgreens’ lead

The pharmacy operator is fine with selling cigarettes -- just not the electronic kind.

Rite Aid: E-Cigs Bad, Tobacco and CBD Rad

Rite Aid Corporation, CVS Health Corp and Walgreens recently announced plans to sell cannabidiol, or CBD, products in 2,500 stores across 19 states.

Retailers Signal Increased Commercial Interest In CBD

The negative impact of the pharmacy retailer's disappointing Q4 update last week continued to weigh on the stock.

Why Rite Aid Corporation Stock Fell Today

Rite Aid (RAD) posts narrower-than-expected loss in fourth-quarter fiscal 2019. Moreover, it issues a soft outlook for fiscal 2020.

Rite Aid (RAD) Falls Despite Narrower-Than-Expected Q4 Loss

The pharmacy retailer's net loss wasn't as bad as expected. But its sales came in well below estimates.

Rite Aid Continued to Struggle in Q4

Rite Aid Corporation (RAD) CEO John Standley on Q4 2019 Results - Earnings Call Transcript

The long-struggling pharmacy chain's earnings show the company still has a tough road ahead of it.

News for Rite Aid Stock (RAD)